Patient Management in the Early Stages of Alzheimer’s Disease
Wiesje van der Flier, PhD, describes how best to deliver a diagnosis of Alzheimer’s disease in the early stages, including how to discuss diagnostic test results with the patient. She outlines the value of patient involvement in registries and enrollment in clinical trials post diagnosis, before this is discussed in relation to the patient case study. José Luis Molinuevo then concludes the symposium, highlighting the importance of an early diagnosis of Alzheimer’s disease.
Key Learning Objectives for Biogen’s AAT-AD/PD 2018 Symposium:
- Understand the importance of an early diagnosis of Alzheimer’s disease
- Gain insights on the use of cognitive assessment tools to achieve an early diagnosis of Alzheimer’s disease
- Understand how fluid and imaging biomarkers can be used to achieve an accurate and timely diagnosis of Alzheimer’s disease in the early stages
- Increase understanding of management options for patients diagnosed with Alzheimer’s disease in the early stages
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.